The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Association of a Low-Frequency Variant in HNF1A With Type 2 Diabetes in a Latino Population
Open accessAbstract
IMPORTANCE: Latino populations have one of the highest prevalences of type 2 diabetes worldwide. OBJECTIVES: To investigate the association between rare protein-coding genetic variants and prevalence of type 2 diabetes in a large Latino population and to explore potential molecular and physiological mechanisms for the observed relationships. DESIGN, SETTING, AND PARTICIPANTS: Whole-exome sequencing was performed on DNA samples from 3756 Mexican and US Latino individuals (1794 with type 2 diabetes and 1962 without diabetes) recruited from 1993 to 2013. One variant was further tested for allele frequency and association with type 2 diabetes in large multiethnic data sets of 14,276 participants and characterized in experimental assays. MAIN OUTCOME AND MEASURES: Prevalence of type 2 diabetes. Secondary outcomes included age of onset, body mass index, and effect on protein function. RESULTS: A single rare missense variant (c.1522G>A [p.E508K]) was associated with type 2 diabetes prevalence (odds ratio [OR], 5.48; 95% CI, 2.83-10.61; P = 4.4 × 10(-7)) in hepatocyte nuclear factor 1-α (HNF1A), the gene responsible for maturity onset diabetes of the young type 3 (MODY3). This variant was observed in 0.36% of participants without type 2 diabetes and 2.1% of participants with it. In multiethnic replication data sets, the p.E508K variant was seen only in Latino patients (n = 1443 with type 2 diabetes and 1673 without it) and was associated with type 2 diabetes (OR, 4.16; 95% CI, 1.75-9.92; P = .0013). In experimental assays, HNF-1A protein encoding the p.E508K mutant demonstrated reduced transactivation activity of its target promoter compared with a wild-type protein. In our data, carriers and noncarriers of the p.E508K mutation with type 2 diabetes had no significant differences in compared clinical characteristics, including age at onset. The mean (SD) age for carriers was 45.3 years (11.2) vs 47.5 years (11.5) for noncarriers (P = .49) and the mean (SD) BMI for carriers was 28.2 (5.5) vs 29.3 (5.3) for noncarriers (P = .19). CONCLUSIONS AND RELEVANCE: Using whole-exome sequencing, we identified a single low-frequency variant in the MODY3-causing gene HNF1A that is associated with type 2 diabetes in Latino populations and may affect protein function. This finding may have implications for screening and therapeutic modification in this population, but additional studies are required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another example is the p.E508K missense mutation in HNF1A, with carrier frequency of 0.1% of the general population and 0.7% of Latinos,8 which confers up to 5-fold increased risk for type 2 diabetes.9”
From Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations (2018) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
Self-citationAn integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
Self-citationVariance component model to account for sample structure in genome-wide association studies
Kang, H. M., Sul, J. H., Service, S. K., Zaitlen, N. A., Kong, S.-Y., Freimer, N. B., Sabatti, C., & Eskin, E. (2010) · Nature Genetics · doi:10.1038/ng.548 · Cited by 2,817
the DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Morris, A. P., Voight, B. F., Teslovich, T. M., Ferreira, T., Segrè, A. V., Steinthorsdottir, V., Strawbridge, R. J., Khan, H., Grallert, H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2383 · Cited by 1,912
Self-citationTwelve type 2 diabetes susceptibility loci identified through large-scale association analysis
The MAGIC investigators, Voight, B. F., The GIANT Consortium, Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.609 · Cited by 1,761
Self-citationEvolution and functional impact of rare coding variation from deep sequencing of human exomes
Tennessen, J. A., Bigham, A. W., O’Connor, T. D., Fu, W., Kenny, E. E., Gravel, S., McGee, S., Do, R., Liu, X., Jun, G., et al. (2012) · Science · doi:10.1126/science.1219240 · Cited by 1,613
Self-citationLi, B., & Leal, S. M. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.06.024 · Cited by 1,527
Genetic Mapping in Human Disease
Altshuler, D., Daly, M. J., & Lander, E. S. (2008) · Science · doi:10.1126/science.1156409 · Cited by 1,452
Self-citationPrevalence of diabetes and impaired fasting glucose in adults in the U.S. population
Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., Eberhardt, M. S., Flegal, K. M., Engelgau, M. M., Saydah, S. H., Williams, D. E., Geiss, L. S., & Gregg, E. W. (2006) · Diabetes Care · doi:10.2337/dc06-0062 · Cited by 1,210
DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Mahajan, A., Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium, Mexican American Type 2 Diabetes (MAT2D) Consortium, Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) Consortium, Go, M. J., Zhang, W., Below, J. E., Gaulton, K. J., et al. (2014) · Nature Genetics · doi:10.1038/ng.2897 · Cited by 1,034
Self-citation
Cited by
Sorted by citations
Items 101–200 of 262
Cid-Soto, M. A., Martínez-Hernández, A. G., Garcia‐Ortíz, H., Córdova, E. J., Barajas-Olmos, F. M., Centeno-Cruz, F., Contreras-Cubas, C., Mendoza‐Caamal, E., Cicerón-Arellano, I., Morales-Rivera, M. I., et al. (2018) · Gene · doi:10.1016/j.gene.2018.08.076 · Cited by 23
Self-citationBarroso, I. (2021) · Diabetologia · doi:10.1007/s00125-021-05575-4 · Cited by 22
Martagón, A. J., Bello‐Chavolla, O. Y., Arellano‐Campos, O., Almeda‐Valdés, P., Walford, G. A., Cruz‐Bautista, I., Gómez‐Velasco, D., Mehta, R., Muñóz-Hernández, L. L., Sevilla-González, M. D. R., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0384 · Cited by 23
Self-citationVaxillaire, M., Froguel, P., & Bonnefond, A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1202-x · Cited by 24
Leveraging Genetics to Advance Type 2 Diabetes Prevention
Florez, J. C. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002102 · Cited by 22
Self-citationSzabó, M. I., Máté, B., Csép, K., & Benedek, T. (2017) · Biochemical Genetics · doi:10.1007/s10528-017-9827-4 · Cited by 23
High-Throughput Approaches onto Uncover (Epi)Genomic Architecture of Type 2 Diabetes
Dziewulska, A., Dobosz, A. M., & Dobrzyń, A. (2018) · Genes · doi:10.3390/genes9080374 · Cited by 23
Functional Analyses of HNF1A-MODY Variants Refine the Interpretation of Identified Sequence Variants
Malíková, J., Kaci, A., Dušátková, P., Aukrust, I., Torsvik, J., Veselá, K., Kankova, P. D., Njølstad, P. R., Průhová, Š., & Bjørkhaug, L. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa051 · Cited by 22
Self-citationDewey, F. E., Grove, M. E., Priest, J. R., Waggott, D. M., Batra, P., Miller, C. L., Wheeler, M. T., Zia, A., Pan, C., Karczewski, K. J., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005496 · Cited by 23
A novel splice-affecting HNF1A variant with large population impact on diabetes in Greenland
Thuesen, A. C. B., Stæger, F. F., Kaci, A., Solheim, M. H., Aukrust, I., Jørsboe, E., Santander, C. G., Andersen, M. K., Li, Z., Gilly, A., et al. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100529 · Cited by 21
Self-citationWhen is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes
Althari, S., & Gloyn, A. L. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.330 · Cited by 23
Genetic Component of Type 2 Diabetes in a Mexican Population
Sanchez-Pozos, K. A., & Menjívar, M. (2016) · Archives of Medical Research · doi:10.1016/j.arcmed.2016.12.007 · Cited by 22
Merriman, T. R., & Wilcox, P. L. (2018) · Annals of Human Biology · doi:10.1080/03014460.2018.1461929 · Cited by 21
Gallardo-Alvarado, L. N., Tusié-Luna, M. T., Tussié-Luna, M. I., Díaz‐Chávez, J., Segura-Kato, Y., Bargalló‐Rocha, E., Villarreal-Garza, C. M., Herrera, L. A., Herrera-Medina, E. M., & de León, D. F. C. (2019) · BMC Cancer · doi:10.1186/s12885-019-5312-2 · Cited by 21
Billings, L. K., Jablonski, K. A., Warner, A. S., Cheng, Y.-C., McAteer, J. B., Tipton, L., Shuldiner, A. R., Ehrmann, D. A., Manning, A. K., Dabelea, D., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3429 · Cited by 20
Self-citationDeForest, N., Kavitha, B., Hu, S., Isaac, R., Krohn, L., Wang, M., Du, X., De Arruda Saldanha, C., Gylys, J., Merli, E., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100339 · Cited by 21
Self-citationSanchez-Pozos, K. A., Ortiz‐López, M. G., Peña‐Espinoza, B. I., Granados‐Silvestre, M. D. L. Á., Jacinto, V. J., Verleyen, J., Ayele, F. T., Sánchez‐Flores, A., & Menjívar, M. (2018) · Molecular Genetics and Genomics · doi:10.1007/s00438-018-1453-2 · Cited by 21
Yang, T., Yan, C.-Y., Yang, L., Tan, J., Jiang, S., Hu, J., Gao, W., Wang, Q., & Li, Y.-S. (2023) · European Journal of Medical Research · doi:10.1186/s40001-023-01321-1 · Cited by 15
Villalobos‐Comparán, M., Jiménez-Ortega, R. F., Estrada, K., Parra-Torres, A. Y., González‐Mercado, A., Patiño, N., Castillejos-López, M. D. J., Quiterio, M., Fernández-López, J. C., Ibarra, B., et al. (2017) · International Journal of Genomics · doi:10.1155/2017/5831020 · Cited by 18
Self-citationMonogenic Diabetes: Genetics and Relevance on Diabetes Mellitus Personalized Medicine
Sousa, M., & Bruges‐Armas, J. (2019) · Current Diabetes Reviews · doi:10.2174/1573399816666191230114352 · Cited by 18
Cruz‐Bautista, I., Huerta‐Chagoya, A., Moreno-Macías, H., Rodríguez-Guillén, R., Ordóñez-Sánchez, M. L., Segura-Kato, Y., Mehta, R., Almeda‐Valdés, P., Gómez-Munguía, L., Chávez, X. R.-D., et al. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01436-6 · Cited by 20
Self-citationBernardo, E., Vas, M. G. D., Balboa, D., Cuenca-Ardura, M., Bonàs‐Guarch, S., Planas-Fèlix, M., Mollandin, F., Torrens-Dinarès, M., Maestro, M. A., García-Hurtado, J., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.07.007 · Cited by 16
Guerra-García, M. T., Moreno-Macías, H., Ochoa-Guzmán, A., Ordóñez-Sánchez, M. L., Rodríguez-Guillén, R., Vázquez-Cárdenas, P., Ortíz-Ortega, V. M., Peimbert-Torres, M., Aguilar-Salinas, C. A., & Tusié-Luna, M. T. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01346-x · Cited by 17
Self-citationChoi, H. J., Park, H., Zhang, L., Kim, J. H., Kim, Y. A., Yang, J., Pei, Y.-F., Tian, Q., Shen, H., Hwang, J., et al. (2016) · Bone · doi:10.1016/j.bone.2016.07.008 · Cited by 17
Huerta‐Chagoya, A., Schroeder, P. H., Mandla, R., Deutsch, A. J., Zhu, W., Petty, L. E., Yi, X., Cole, J. B., Udler, M. S., Dornbos, P., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05912-9 · Cited by 19
Self-citationMining the Genome for Therapeutic Targets
Florez, J. C. (2017) · Diabetes · doi:10.2337/dbi16-0069 · Cited by 17
Self-citationGain of Function of Malate Dehydrogenase 2 and Familial Hyperglycemia
Jungtrakoon, P., Marucci, A., Pannone, L., Bonnefond, A., Pezzilli, S., Biagini, T., Buranasupkajorn, P., Hastings, T., Mendonça, C., Marselli, L., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab790 · Cited by 17
Iklé, J. M., & Gloyn, A. L. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0067 · Cited by 14
SPINK5andADRB2haplotypes are risk factors for asthma in Mexican pediatric patients
Martínez-Aguilar, N. E., Río-Navarro, B. E. D., Navarro-Olivos, E., Garcia‐Ortíz, H., Orozco, L., & Jiménez‐Morales, S. (2014) · Journal of Asthma · doi:10.3109/02770903.2014.966913 · Cited by 16
Self-citationBazzazzadehgan, S., Shariat‐Madar, Z., & Mahdi, F. (2025) · Biomolecules · doi:10.3390/biom15030414 · Cited by 19
Lipase Genetic Variants in Chronic Pancreatitis: When the End Is Wrong, All’s Not Well
Molven, A., Fjeld, K., & Lowe, M. E. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.019 · Cited by 15
Xu, K., Jiang, L., Zhang, M., Zheng, X., Gu, Y., Wang, Z., Cai, Y., Dai, H., Shi, Y., Zheng, S., et al. (2016) · Medicine · doi:10.1097/md.0000000000003604 · Cited by 15
The Contribution of Low-Frequency and Rare Coding Variation to Susceptibility to Type 2 Diabetes
Flannick, J. A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1142-5 · Cited by 16
Self-citationWu, B., Pankow, J. S., & Guan, W. (2015) · Genetic Epidemiology · doi:10.1002/gepi.21913 · Cited by 14
Type 2 Diabetes Prevention: Implications of Hemoglobin A1c Genetics
Leong, A., & Meigs, J. B. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.351 · Cited by 13
Cases in Precision Medicine: Genetic Testing to Predict Future Risk for Disease in a Healthy Patient
Rasouly, H. M., Aggarwal, V. S., Bier, L., Goldstein, D. B., & Gharavi, A. G. (2021) · Annals of Internal Medicine · doi:10.7326/m20-5713 · Cited by 13
Ishigaki, K., Sakaue, S., Terao, C. C., Luo, Y., Sonehara, K., Yamaguchi, K., Amariuta, T., Too, C. L., Laufer, V. A., Scott, I. C., et al. (2021) · medRxiv · doi:10.1101/2021.12.01.21267132 · Cited by 13
Bartolomé, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010501 · Cited by 15
Genome-Wide Studies of Type 2 Diabetes and Lipid Traits in Hispanics
Below, J. E., & Parra, E. J. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0737-3 · Cited by 15
Kaci, A., Keindl, M., Solheim, M. H., Njølstad, P. R., Bjørkhaug, L., & Aukrust, I. (2018) · Scientific Reports · doi:10.1038/s41598-018-29448-w · Cited by 12
Self-citationHuerta‐Chagoya, A., Moreno-Macías, H., Sevilla-González, M. D. R., Rodríguez-Guillén, R., Ordóñez-Sánchez, M. L., Gómez‐Velasco, D., Muñóz-Hernández, L. L., Segura-Kato, Y., Arellano‐Campos, O., Cruz‐Bautista, I., et al. (2020) · Genes · doi:10.3390/genes11010114 · Cited by 12
Self-citationGenetic Architecture of Type 2 Diabetes
Prasad, R. B., & Groop, L. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch14 · Cited by 12
Diabetes in Population Isolates: Lessons from Greenland
Grarup, N., Moltke, I., Albrechtsen, A., & Hansen, T. F. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.320 · Cited by 12
Rajabli, F., Benchek, P. H., Tosto, G., Kushch, N. A., Sha, J., Bazemore, K., Zhu, C., Lee, W., Haut, J., Hamilton‐Nelson, K. L., et al. (2023) · medRxiv · doi:10.1101/2023.07.06.23292311 · Cited by 11
Maturity onset diabetes of the young and beyond: the changing face of single-gene diabetes
Laver, T. W., & Patel, K. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf172 · Cited by 11
Prioritization of genes associated with type 2 diabetes mellitus for functional studies
Tan, W. X., Sim, X., Khoo, C. M., & Teo, A. K. K. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00836-1 · Cited by 10
Where to for precision treatment of HNF1A-MODY?
Bonner, C., & Saponaro, C. (2022) · Diabetologia · doi:10.1007/s00125-022-05696-4 · Cited by 10
Bello‐Chavolla, O. Y., & Aguilar-Salinas, C. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-41559-8_7 · Cited by 10
Self-citationGenetics and Clinical Characteristics of PPARγ Variant-Induced Diabetes in a Chinese Han Population
Gong, S., Han, X., Li, M., Cai, X., Liu, W., Luo, Y., Zhang, S.-M., Zhou, L., Ma, Y., Huang, X., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.677130 · Cited by 10
Pharmacogenetics and target identification in diabetes
Pearson, E. R. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.02.005 · Cited by 12
Potential Role of SUMO and SUMOylation in the Pathogenesis of Diabetes Mellitus
Sadeghi, M., Dehnavi, S., Shohan, M., Jamialahmadi, T., Sathyapalan, T., & Sahebkar, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220817142848 · Cited by 9
Mexican Samples, Latino DNA: The Trajectory of a National Genome in Transnational Science
Vasquez, E. E., & Deister, V. G. (2019) · Engaging Science Technology and Society · doi:10.17351/ests2019.199 · Cited by 9
HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR
Fan, Z., Fan, K., Deng, S., Gong, Y., Qian, Y., Huang, Q., Yang, C., He, C., Jin, K., Luo, G., et al. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz169 · Cited by 9
Schuch, J. B., Paixão‐Côrtes, V. R., Friedrich, D. C., & Tovo‐Rodrigues, L. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32431 · Cited by 8
Stalbow, L. A., Preuss, M. H., Smit, R. A. J., Chami, N., Bjørkhaug, L., Aukrust, I., Gloyn, A. L., & Loos, R. J. F. (2022) · Diabetologia · doi:10.1007/s00125-022-05806-2 · Cited by 9
Self-citationKavitha, B., Ranganathan, S., Gopi, S., Vetrivel, U., Nagarajan, H., Mohan, V., & Venkatesan, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1177268 · Cited by 9
Phenotypic and Genetic Diversity in Diabetes Across Populations
Deutsch, A. J., & Udler, M. S. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf234 · Cited by 10
Dissecting the Etiology of Type 2 Diabetes in the Pima Indian Population
Pearson, E. R. (2015) · Diabetes · doi:10.2337/dbi15-0016 · Cited by 8
Validation of a multi-omics strategy for prioritizing personalized candidate driver genes
Liang, L., Song, L., Yang, Y., Tian, L., Li, X., Wu, S., Huang, W., Ren, H., Tang, N., & Ding, K. (2016) · Oncotarget · doi:10.18632/oncotarget.9540 · Cited by 8
The Diabetes Management Education Program in South Texas: An Economic and Clinical Impact Analysis
Kash, B. A., Lin, S.-H., Baek, J., & Ohsfeldt, R. L. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00345 · Cited by 8
Morales-Rivera, M. I., Alemón‐Medina, R., Martínez-Hernández, A. G., Contreras-Cubas, C., Altamirano-Bustamante, N. F., Gómez-Garduño, J., Mendoza‐Caamal, E., Nunez-Gonzalez, J., García‐Álvarez, R., Revilla, M., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17101385 · Cited by 7
Self-citationTranscriptome-wide association studies associated with Crohn’s disease: challenges and perspectives
Jia, K., & Shen, J. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01204-w · Cited by 7
Chow, W. S., Buysman, E. K., Rupnow, M. F. T., Aguilar, R. B., & Henk, H. J. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1100598 · Cited by 7
Genome-Wide Association Studies of Type 2 Diabetes
SLADEK, R. M., & Prokopenko, I. (2016) · Springer eBooks · doi:10.1007/978-3-319-01574-3_2 · Cited by 7
Bansal, V., Winkelmann, B. R., Dietrich, J. W., & Boehm, B. O. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1258982 · Cited by 7
Nagao, Y. (2015) · Scientific Reports · doi:10.1038/srep17156 · Cited by 7
The Continuing Evolution of Precision Health in Type 2 Diabetes: Achievements and Challenges
Lin, Y., & Wessel, J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1137-2 · Cited by 7
Structural basis of ethnic-specific variants of PAX4 associated with type 2 diabetes
Hosoe, J., Ken, S., Miya, F., Kato, T., Tsunoda, T., Okada, Y., Horikoshi, M., Shojima, N., Yamauchi, T., & Kadowaki, T. (2021) · Human Genome Variation · doi:10.1038/s41439-021-00156-8 · Cited by 7
Andersen, M. K., Jørsboe, E., Skotte, L., Hanghøj, K., Sandholt, C. H., Moltke, I., Grarup, N., Kern, T., Mahendran, Y., Søborg, B., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008544 · Cited by 7
A Systematic Review of the use of Precision Diagnostics in Monogenic DiabetesPreprint
Murphy, R., Colclough, K., Pollin, T. I., Iklé, J. M., Svalastoga, P., Maloney, K. A., Saint‐Martin, C., Molnes, J., Initiative, A. P. M. D., Misra, S., et al. (2023) · medRxiv · doi:10.1101/2023.04.15.23288269 · Cited by 7
Self-citationTowards the recognition of oligogenic forms of type 2 diabetes
Collen, L. L., Froguel, P., & Bonnefond, A. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.06.006 · Cited by 6
Diabetic Retinopathy in Hispanics: A Perspective on Disease Burden
Mora, N., Kempen, J. H., & Sobrin, L. (2018) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.08.021 · Cited by 6
Chacon-Camacho, O. F., Sobreira, N. L. D. M., You, J., Piña-Aguilar, R. E., Villegas-Ruíz, V., & Zenteno, J. C. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37683 · Cited by 6
Personalized Oral Medicine and the Contemporary Health Care Environment
Slavkin, H. C. (2015) · Springer eBooks · doi:10.1007/978-3-319-23297-3_1 · Cited by 5
Circulating microRNAs associated with prediabetes and geographic location in Latinos
Flowers, E., Ramírez-Mares, J.-D., Velázquez-Villafaña, M., Rangel-Salazar, R., Sucher, A., Kanaya, A. M., Aouizerat, B. E., & Lazo-de-la-Vega-Monroy, M.-L. (2021) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00917-1 · Cited by 5
Sagen, J. V., Bjørkhaug, L., Haukanes, B. I., Grevle, L., Molnes, J., Nedrebø, B. G., Søvik, O., Njølstad, P. R., Johansson, S., & Molven, A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.001 · Cited by 5
Self-citationWang, L., Beecham, A. H., Dueker, N., Blanton, S. H., Rundek, T., & Sacco, R. L. (2015) · Human Genetics · doi:10.1007/s00439-015-1592-z · Cited by 5
Precision Nutrition for Type 2 Diabetes
Ben-Yacov, O., & Rein, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_12 · Cited by 4
Rao, J., Sinn, M., Pelzer, U., Riess, H. B., Oettle, H., Demir, İ. E., Friess, H., Jäger, C., Steiger, K., & Muckenhuber, A. (2024) · The Journal of Pathology Clinical Research · doi:10.1002/2056-4538.12377 · Cited by 4
Nocera, D., Menniti, M., Belviso, S., Bond, H. M., Lanzillotta, D., Spoleti, C. B., Guagliardi, M. R., Malatesta, P., Trapasso, F., Irace, C., et al. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01298-6 · Cited by 4
Jurado-Camacho, P. A., Cid-Soto, M. A., Barajas-Olmos, F. M., Garcia‐Ortíz, H., Baca, P., Martínez-Hernández, A. G., Centeno-Cruz, F., Contreras-Cubas, C., González-Villalpando, M. E., Saldaña‐Alvarez, Y., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.807381 · Cited by 4
Self-citationArya, R., Puppala, S., Farook, V. S., Chittoor, G., Jenkinson, C. P., Blangero, J., Hale, D. E., Duggirala, R., & Almasy, L. A. (2015) · Springer eBooks · doi:10.1007/978-3-662-46306-2_12 · Cited by 4
Self-citationGenetics of Diabetes and Diabetic Complications
Prasad, R. B., Ahlqvist, E., & Groop, L. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_6 · Cited by 5
Spontaneous recovery and the multiple timescales of human motor memoryPreprint
Orozco, S. P., Albert, S. T., & Shadmehr, R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.24.006023 · Cited by 4
Berumen, J., Kuri-Morales, P., Torres, J. M., Barrera, E., Baca, P., Rivas, F., Ramírez-Tirado, L., González-Carballo, C., Zarza, A., Vecchyo-Tenorio, G. D., et al. (2026) · Lancet Public Health · doi:10.1016/s2468-2667(25)00305-6 · Cited by 1
Syed, M., Walter, C., & Meyer, H. V. (2026) · Bioinformatics · doi:10.1093/bioinformatics/btag612 · Cited by 3
Plasma MicroRNAs Related to Metabolic Syndrome in Mexican Women
Ramírez-Solano, M. A., Córdova, E. J., Orozco, L., & Tejero, M. E. (2023) · Lifestyle Genomics · doi:10.1159/000534041 · Cited by 3
Self-citationObesity and Metabolic Syndrome in Latin America
Ycaza, A. E. E. D., & Cardenas, S. M. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_4 · Cited by 3
CFTR pathogenic variants spectrum in a cohort of Mexican patients with cystic fibrosis
Martínez-Hernández, A. G., Mendoza‐Caamal, E., Mendiola-Vidal, N. G., Barajas-Olmos, F. M., Villafán-Bernal, J. R., Jiménez-Ruíz, J. L., Monge-Cázares, T., Garcia‐Ortíz, H., Contreras-Cubas, C., Centeno-Cruz, F., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28984 · Cited by 3
Self-citationAdvancing equity in genomic medicine for rheumatology
Díaz‐Peña, R., & Adelowo, O. O. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01156-y · Cited by 3
Mendiola-Vidal, N. G., Contreras-Cubas, C., Barajas-Olmos, F. M., Villafán-Bernal, J. R., Yanez‐Felix, A. L., Garcia‐Ortíz, H., Centeno-Cruz, F., Mendoza‐Caamal, E., Aláez‐Verson, C., Jiménez-Ruíz, J. L., et al. (2024) · Life · doi:10.3390/life14111445 · Cited by 3
Self-citationAndersen, M. K., Grarup, N., Moltke, I., Albrechtsen, A., & Hansen, T. F. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.02.010 · Cited by 3
Leroux, M., Boutchueng-Djidjou, M., & Faure, R. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031030 · Cited by 3
Ma, Y., Luo, Y., Gong, S., Zhou, X., Li, Y., Liu, W., Zhang, S., Cai, X., Ren, Q., Zhou, L., et al. (2020) · Diabetes · doi:10.2337/db20-0564 · Cited by 3
Flores-Alvarado, L. J. (2014) · Medicinal Chemistry · doi:10.4172/2161-0444.1000232 · Cited by 3
Grant, S. F. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_11-1 · Cited by 3
Florez, J. C., Udler, M. S., & Hanson, R. L. (2021) · Europe PMC (PubMed Central) · Cited by 3
Self-citationGoto, A., Chen, B. H., Chan, K. H. K., Lee, C., Nelson, S. C., Crenshaw, A., Bookman, E., Margolis, K. L., Sale, M. M., Ng, M. C. Y., et al. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12648 · Cited by 3
The Role of Pharmacogenomics in Diabetes
Lam, Y. W. F., Duggirala, R., Jenkinson, C. P., & Arya, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812626-4.00009-7 · Cited by 4
Self-citationEfficacy and safety of ertugliflozin in Hispanic/Latino patients with type 2 diabetes mellitus
Liu, J., Tarasenko, L. C., Pong, A., Huyck, S. B., Patel, S. M., Hickman, A., Mancuso, J. P., Ellison, M. C., Gantz, I., & Terra, S. G. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1760227 · Cited by 3
Metadata
- Authors
- Estrada, K., Aukrust, I., Bjørkhaug, L., Burtt, N. P., Mercader, J. M., García-Ortiz, H., Huerta-Chagoya, A., Moreno-Macías, H., Walford, G., Flannick, J., Williams, A. L., Gómez-Vázquez, M. J., Fernandez-Lopez, J. C., Martínez-Hernández, A., Centeno-Cruz, F., Mendoza-Caamal, E., Revilla-Monsalve, C., Islas-Andrade, S., Córdova, E. J., Soberón, X., González-Villalpando, M. E., Henderson, E., Wilkens, L. R., Le Marchand, L., Arellano-Campos, O., Ordóñez-Sánchez, M. L., Rodríguez-Torres, M., Rodríguez-Guillén, R., Riba, L., Najmi, L. A., Jacobs, S. B. R., Fennell, T., Gabriel, S., Fontanillas, P., Hanis, C. L., Lehman, D. M., Jenkinson, C. P., Abboud, H. E., Bell, G. I., Cortes, M. L., Boehnke, M., González-Villalpando, C., Orozco, L., Haiman, C. A., Tusié-Luna, T., Aguilar-Salinas, C. A., Altshuler, D., Njølstad, P. R., Florez, J. C., & MacArthur, D. G.
- Affiliations
- Broad Institute (US)
- University of Bergen (NO)
- Haukeland University Hospital (NO)
- Instituto Nacional de Medicina Genómica, Tlalpan, Mexico City, Mexico
- Instituto de Investigaciones Biomédicas, UNAM Unidad de Biología Molecular y Medicina Genómica, UNAM/INCMNSZ, Coyoacán, Mexico City, Mexico
- Universidad Autónoma Metropolitana (MX)
- Harvard University (US)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- National Institute of Genomic Medicine (MX)
- Unidad de Investigación Médica en Enfermedades Metabólicas, CMN SXXI, Instituto Mexicano del Seguro Social, Mexico City
- Instituto Nacional de Salud Pública (MX)
- University of Southern California (US)
- University of Hawaii Cancer Center (US)
- Epidemiology Program, University of Hawaii Cancer Center, Honolulu
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, Mexico City, Mexico
- The University of Texas Health Science Center at Houston (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Chicago (US)
- Broad Institute of Harvard and MIT, Cambridge, Massachusetts
- University of Michigan (US)
- Centro de Estudios en Diabetes, Unidad de Investigacion en Diabetes y Riesgo Cardiovascular, Centro de Investigacion en Salud Poblacional, Instituto Nacional de Salud Publica, Mexico City, Mexico
- Instituto de Investigaciones Biomédicas, UNAM Unidad de Biología Molecular y Medicina Genómica, UNAM/INCMNSZ, Coyoacán, Mexico City, Mexico17Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, Mexico City, Mexico
- Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts3Department of Medicine, Harvard Medical School, Boston, Massachusetts7Center for Human Genetic Research and Diabetes Research Center (Diabetes Unit),
- ORCID
- Estrada, Karol
- Aukrust, Ingvild
- Bjørkhaug, Lise
- Burtt, Noël P.
- Mercader, Josep M.
- Moreno-Macías, Hortensia
- Flannick, Jason
- Williams, Amy L.
- Martínez-Hernández, Angélica
- Centeno-Cruz, Federico
- Córdova, Emilio J.
- Soberón, Xavier
- Henderson, E.
- Wilkens, Lynne R.
- Jacobs, Suzanne B.R.
- Gabriel, Stacey
- Fontanillas, Pierre
- Hanis, Craig L.
- Lehman, Donna M.
- Jenkinson, Christopher P.
- Boehnke, Michael
- Orozco, Lorena
- Haiman, Christopher A.
- Aguilar-Salinas, Carlos A.
- Altshuler, David
- Njølstad, Pål R.
- MacArthur, Daniel G.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2014-06-11
- Volume
- 311
- Issue
- 22
- Pages
- 2305
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC4425850
- OpenAlex
- W2055830789
- Cited by
- 259
- References
- 57
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 22 · 2023: 24 · 2022: 24 · 2021: 21 · 2020: 15 · 2019: 22 · 2018: 30 · 2017: 22 · 2016: 31 · 2015: 23 · 2014: 6
- FWCI
- 17.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- Funders
- Consejo Nacional de Ciencia y Tecnología
- Helse Vest
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL024799, P01HL045522, R01HL24799)
- National Cancer Institute (R35CA053890, CA164973, R01CA144034, R01CA080205, U01CA063464, R37CA054281, R35-CA53890, R01CA054281, R01 CA 80205, R01CA063464, UM1CA164973, CA054281, CA063464, R01CA055069, U01CA164973)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK085526, R01 DK057295, U01DK057295, U01DK085501, U01DK062370, R01DK042273, R01DK047482, R01DK053889, R01DK098032, R01DK033665, P30DK020572)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- type 2 diabetes, HNF1A, rare missense variants, Latino population, Mexican Americans, MODY3, genetic susceptibility, transactivation activity, age of onset, body mass index, exome sequencing, genetic association, diabetes prevalence, protein-coding variants, age at onset of diabetes
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 2, Female, Genotype, Hispanic or Latino, Humans, Male, Mexico, Middle Aged, United States, Sequence Analysis, DNA, Age of Onset, Mutation, Missense, Hepatocyte Nuclear Factor 1-alpha
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
